13D Filing: Saba Capital and Clough Global Opportunities Fund (GLO)

This Amendment No. 9 amends and supplements the statement
on Schedule 13D filed with the Securities and Exchange Commission (the
SEC) on 1/6/17, Amendment No. 1 filed on 1/27/17, Amendment No 2 filed
on 2/13/17, Amendment No 3 filed on 3/13/17, Amendment No 4 filed on
4/10/17, Amendment No 5 filed on 4/20/17, Amendment No 6 filed on 4/28/17,
Amendment No 7 filed on 7/11/17, Amendment No 8 filed on 11/13/17, and
Amendment No 9. Amendment No. 1, Amendment No. 2, Amendment No. 3,
Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7,
Amendment No. 8, Amendment No. 9, and the Original Schedule 13D, with
respect to the shares of common stock, (the Shares), of Clough Global
Opportunities Fund (the Issuer). Capitalized terms used herein and not
otherwise defined in this Amendment No. 9 have the meanings set forth in
the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No.
3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, and
Amendment No.8. This Amendment No. 9 amends Items 3 and 5 as set forth
below.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Funds for the purchase of the Common Shares were derived
from the subscription proceeds from investors in SCMF, SCMF II, SCLMF,
SCS, SCEF 1, SCEF 2, and Saba Closed-End Funds ETF and the capital
appreciation thereon and margin account borrowings made in the ordinary
course of business. In such instances, the positions held in the margin
accounts are pledged as collateral security for the repayment of debit
balances in the account, which may exist from time to time. Since other
securities are held in the margin accounts, it is not possible to
determine the amounts, if any, of margin used to purchase the Common
Shares reported herein. A total of $7,940,050 was paid to acquire the
Common Shares reported herein.

INTEREST IN SECURITIES OF THE ISSUER

See rows (11) and (13) of the cover pages to this
Schedule 13D/A for the aggregate number of Common Shares and percentages
of the Common Shares beneficially owned by each of the Reporting Persons.
The percentages used in this Schedule 13D/A are calculated based upon
32,224,411 shares of common stock outstanding as of 11/13/2017, as
disclosed in the company’s Certified Shareholder Report Form SC- TO I/A
filed 11/13/2017.

See rows (7) through (10) of the cover pages to this
Schedule 13D/A for the number of Common Shares as to which each Reporting
Person has the sole or shared power to vote or direct the vote and sole or
shared power to dispose or to direct the disposition.

The transactions in the Shares effected since the filing
of the Amendment No 8 by Saba Capital, which were all in the open market,
are set forth in Schedule A, and are incorporated herein by reference.

No person other than the Reporting Persons and the Saba
Entities is known to have the right to receive, or the power to direct the
receipt of dividends from, or proceeds from the sale of, such Common
Shares.

Not applicable.